GL1X · GenesisL1 explorer

Research workbench

Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29

Analyse Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EQS
Type
protein
Length
1,086 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacylase sirtuin-5, mitochondrial
EC
3.5.1.-
UniProt
Q9NXA8
Ligands
BV8, ZN
Pockets
11 · best druggability 0.82

Structure

x-ray diffraction · 4 distinct chains · 38% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein26938% helix, 19% strandQ9NXA8
BNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein26839% helix, 19% strandQ9NXA8
CNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein27438% helix, 19% strandQ9NXA8
DNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein27537% helix, 19% strandQ9NXA8

Ligands and binding sites

  • BV8 · 3-[[(~{Z})-~{C}-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]sulfanyl-~{N}-[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]carbonimidoyl]amino]propanoic acid · ligand · 4 copies · chains A, D, B, C
  • ZN · Zinc ion · metal · 4 copies · chains A, B, C, D
  • EDO · 1,2-ethanediol · additive · 15 copies · chains A, B, C, D
  • BU2 · 1,3-butanediol · additive · 8 copies · chains A, B, C, D
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110210.820.83102BV8, EDO
29330.800.8294BV8, EDO, BU2
34600.770.8558BV8, EDO, DMS
44430.770.8559BV8, EDO, BU2
58330.720.7793BU2

Interfaces

3 interfaces between chains.

  • A–D · 527 Ų buried · 4 hydrogen bonds · protein-protein
  • B–C · 490 Ų buried · 4 hydrogen bonds · protein-protein
  • B–D · 357 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6EQS · Human Sirt5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29 · the same entry in another collection · chain D against D, TM-score 1.00
  • Q9NXA8 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase sirtuin-5… · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.